-17.11% percent quarterly performance for TELA Bio Inc (TELA) is not indicative of the underlying story

On Friday, TELA Bio Inc (NASDAQ: TELA) opened lower -8.56% from the last session, before settling in for the closing price of $5.14. Price fluctuations for TELA have ranged from $4.23 to $10.84 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 49.61%. Company’s average yearly earnings per share was noted 25.34% at the time writing. With a float of $17.23 million, this company’s outstanding shares have now reached $24.49 million.

Considering the fact that the conglomerate employs 227 people, you should pay attention to its efficiency factor.

TELA Bio Inc (TELA) Insider Activity

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of TELA Bio Inc is 30.12%, while institutional ownership is 47.15%. The most recent insider transaction that took place on Dec 05 ’23, was worth 14,688. In this transaction Chief Business Officer of this company bought 2,600 shares at a rate of $5.65, taking the stock ownership to the 35,511 shares. Before that another transaction happened on Nov 14 ’23, when Company’s Chief Executive Officer bought 11,000 for $4.54, making the entire transaction worth $49,976. This insider now owns 303,634 shares in total.

TELA Bio Inc (TELA) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.53) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 25.34% per share during the next fiscal year.

TELA Bio Inc (NASDAQ: TELA) Trading Performance Indicators

Check out the current performance indicators for TELA Bio Inc (TELA). In the past quarter, the stock posted a quick ratio of 3.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.84.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.67, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.15 in one year’s time.

Technical Analysis of TELA Bio Inc (TELA)

Compared to the last year’s volume of 0.16 million, its volume of 0.76 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 16.69%. Additionally, its Average True Range was 0.35.

During the past 100 days, TELA Bio Inc’s (TELA) raw stochastic average was set at 12.42%, which indicates a significant increase from 1.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.58% in the past 14 days, which was higher than the 57.24% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $5.32, while its 200-day Moving Average is $6.03. Nevertheless, the first resistance level for the watch stands at $5.17 in the near term. At $5.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.89. If the price goes on to break the first support level at $4.45, it is likely to go to the next support level at $4.21. Should the price break the second support level, the third support level stands at $3.74.

TELA Bio Inc (NASDAQ: TELA) Key Stats

There are currently 24,655K shares outstanding in the company with a market cap of 115.90 million. Presently, the company’s annual sales total 58,450 K according to its annual income of -46,660 K. Last quarter, the company’s sales amounted to 16,600 K and its income totaled -5,660 K.